Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart

Data: The Malaria Atlas Project; Map: Harry Stevens/Axios

The fight against malaria in the past couple decades has largely had a positive trajectory — since 2000, there have been 7 million lives saved and about 1 billion cases prevented — but recently there's been pockets of plateauing or increased infections in the world.

Why it matters: Malaria parasites are starting to show more resistance against insecticides and drug treatments. Combined with political instability and lack of necessary funding, the goal of eliminating malaria now requires urgent action with new tools no longer using the "one size fits all" method, a group of malaria experts tell Axios.

"We need to get the right combination of interventions to the right people at the right place to save lives."
— Jennifer Gardy of the Gates Foundation

Background: The female Anopheles mosquito is the vector of malaria parasites (there are now more than 100 species). When diagnosed early, malaria is considered treatable for most patients, depending on the particular parasite.

  • Plasmodium falciparum, found mostly in Africa, is the most deadly parasite as it can cause cerebral malaria. Plasmodium vivax tends to be less deadly but is more prominent throughout the world, including in South America.

What's new: "For the first time [in recent history] we're seeing cases rise in high burden areas," says Michal Fishman of the nonprofit Malaria No More.

  • The reasons for the uptick are mainly due to 3 issues: higher population movement from refugees, a lack of necessary funding, and the parasites are becoming more resistance to insecticides and drug treatments, according to Simon Hay of the University of Washington's Institute for Health Metrics and Evaluation (IHME) who tracks malaria via maps.
  • Malaria was eliminated in the U.S. in 1951, but the country still has the Anopheles mosquitos that can bite an infected person and transmit to others.

The group of experts from nonprofit and for-profit groups tell Axios the following steps are needed...

1. Decisive actions from governments are key, mainly through policy and funding.

  • "Political will is such a critical factor in driving results in Africa," says Abbott's Damian Halloran. Fishman agrees, and points to Zambia's president as one who tracks their malaria effort every day.
  • The World Health Organization, which has called for 10 countries to be malaria-free by 2020, pointed out last week that China is a good example after eliminating malaria "became the joint goal of 13 ministries, including health, finance, industry, and education. The results were impressive and the country has gone from 30 million cases in the 1940s to zero indigenous cases in 2017."
  • Yes, but: Hay warns there's a $2 billion funding shortfall in WHO's malaria plan.

2. New tracking technologies can assist.

  • Real-time mapping is a tool researchers and advocates can use to pinpoint where to focus resources and expertise.
  • The Malaria Atlas Project at the University of Oxford and IHME published 2 studies in The Lancet on Wednesday mapping P. falciparum and P. vivax. "We've seen spectacular successes in many places, but a plateauing in some places and a resurgence in others," Hay says. Venezuela and Yemen are 2 places in particular that have seen more malaria due to political instability, Hay adds.
  • IR Mapper tracks reports of insecticide resistance in mosquitos.

3. New diagnostics and preventative measures.

  • Bed nets need to be improved to combat growing drug resistance, according to Patrick Sieyes, regional director for Vestergaard, a company that produces nets. While long-lasting treated nets are considered to be a key reason malaria cases have dropped, "we're seeing a plateau and even a reversal [in some cases] ... we're very concerned," Sieyes says. In response, the company recently developed a new version of the Permanet plus the IR Mapper app noted above.
  • Fast, reliable testing is needed to help people immediately determine if the person has malaria or not, Halloran says. Abbott has created rapid diagnostic tests for malaria that can detect it even in people who show no visible symptoms of the disease, he says. This is important because many other illnesses show similar symptoms, he adds.
  • CRISPR technology can be used to help quickly detect viral biomarkers of malaria via a saliva or urine sample, says Trevor Martin, co-founder and CEO of Mammoth Biosciences, which is developing such a test.
  • Gardy says that genomic epidemiology is the way to move forward because "by reading the DNA sequence of either the parasite or the mosquito vector," a plan of action can be created for that region.

An effective vaccine would be another important tool in the arsenal, Gardy says. A pilot program has started in Malawi and Ghana testing a new malaria vaccine called RTS,S against the deadly P. falciparum, but it faces some issues like efficacy and accessibility (it requires 4 shots). It will be brought into Kenya in July.

Go deeper:

Go deeper

Erica Pandey, author of @Work
2 hours ago - Economy & Business

What's really going on with the labor market

Source: YCharts

The labor market is showing some signs of improvement: Jobless claims fell to 730,000 — a dramatic drop from 841,000 the previous week. And the latest jobs report showed a pandemic-era low unemployment rate of 6.3%

But, but, but: That's not the full story, experts say.

Felix Salmon, author of Capital
2 hours ago - Economy & Business

Markets see rare convergence milestone

Expand chart
Data: YCharts; Chart: Axios Visuals

A milestone was reached in the markets Thursday: The yield on the 10-year Treasury note rose to match the dividend yield on the S&P 500

Why it matters: The two yields have been inverted since the beginning of last year, which is historically unusual.

Mike Allen, author of AM
3 hours ago - Economy & Business

First look: Business puts muscle behind Biden

Business Roundtable, the voice of America's top CEOs, today launched "Move the Needle," a campaign to support President Biden in rolling out COVID vaccines, increasing vaccine uptake and encouraging masks.

What they're saying: "Masks and vaccines are working. Now is the time to keep at it, overcome pandemic fatigue, and double down on the measures that will end this public health and economic crisis, said Business Roundtable president and CEO Josh Bolten.